Mirtazapine Zentiva (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases norepinephrine release, and by antagonizing serotonin 5‑HT2 and 5‑HT3 receptors while stimulating 5‑HT1A receptors. This combined effect enhances both noradrenergic and serotonergic neurotransmission, addressing the neurochemical imbalances associated with depression.

The appropriate dose of Mirtazapine Zentiva is determined by the prescribing healthcare professional based on the individual’s clinical condition, response to therapy, and tolerability. Dosage adjustments are made according to medical judgment and patient-specific factors.

Safety data for mirtazapine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To order Mirtazapine Zentiva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and necessary import documentation.

Mirtazapine belongs to the NaSSA class, differing from SSRIs and SNRIs by its combined antagonism of certain serotonin receptors and α2‑adrenergic blockade. This profile often results in strong sedative effects and appetite stimulation, which can be advantageous for patients with insomnia or weight loss, but may be less suitable for those concerned about weight gain.

Mirtazapine Zentiva should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Mirtazapine Zentiva is taken orally, usually once daily in the evening to take advantage of its sedative properties. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include agranulocytosis, severe liver injury, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should be alert for signs of infection, jaundice, unexplained rash or blistering, and any sudden changes in mood or thoughts of self‑harm, and seek immediate medical attention if they occur.

Mirtazapine is contraindicated in patients who have taken monoamine oxidase inhibitors (MAOIs) within the past 14 days, and in individuals with known hypersensitivity to the drug. Caution is advised for patients with severe hepatic impairment, uncontrolled epilepsy, or a history of severe allergic reactions.